Trastuzumab deruxtecan

Trastuzumab deruxtecan

Cat Number
API1826843815
CAS Number
1826843-81-5

If you have any other questions, please contact our experts.

CAS Number
1826843-81-5
Description
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
Molecular Weight
145 kDa (average)
Purity
98.49% (SEC-HPLC)
You Might Also Like
Baloxavir-d4
Baloxavir-d4

Cat NO.: API2415027802
CAS NO.: 2415027-80-2

View Details
Binimetinib
Binimetinib

Cat NO.: API606143899
CAS NO.: 606143-89-9

View Details
Fluoxetine succinate ester
Fluoxetine succinate ester

Cat NO.: API1026723454
CAS NO.: 1026723-45-4

View Details
Trifluoromethyl Dechloro Ethylcloprostenolamide
Trifluoromethyl Dechloro Ethylcloprostenolamide

Cat NO.: API1005193645
CAS NO.: 1005193-64-5

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top